| Control Group | S-ketamine Group | Media Difference (95%CI) | P-value |
---|---|---|---|---|
Global QoR-15 | Â | Â | Â | Â |
POD1 | 119.0 (114.0–123.5) | 124.0 (119.5–128.0) | -5 (-8 to -2) | 0.002* |
POD2 | 132.0 (126.5–141.5) | 140.0 (133.0–145.0) | -6 (-10 to -2) | 0.004* |
QoR-15 dimensions Pain | Â | Â | Â | Â |
POD1 | 16.0 (15.0–17.0) | 17.0 (16.0–18.0) | -1 (-2 to 0) | 0.027* |
POD2 | 18.0 (17.0–19.0) | 19.0 (18.0–20.0) | -1 (-2 to 0) | 0.024* |
Physical comfort | Â | Â | Â | Â |
POD1 | 38.0 (35.0–40.0) | 39.0 (36.0–42.5) | -2 (-4 to 0) |  0.041* |
POD2 | 45.0 (42.0–47.0) | 47.0 (45.0–50.0) | -2 (-4 to -1) | 0.005* |
Physical independence | Â | Â | Â | Â |
POD1 | 17.0 (15.0–18.0) | 17.0 (17.0–18.0) | -1 (-1 to 0) | 0.061 |
POD2 | 18.0 (18.0–19.0) | 18.5 (17.0–19.5) | 0 (-1 to 0) |  0.381 |
Physical support | Â | Â | Â | Â |
POD1 | 17.0 (16.0–18.0) | 17.0 (16.0–18.0) | 0 (-1 to 1) |  0.762 |
POD2 | 18.0 (17.0–20.0) | 19.0 (17.0–19.5) | 0 (-1 to 1) | 0.789 |
Emotional state | Â | Â | Â | Â |
POD1 | 33.0 (31.0–34.0) | 35.0 (31.5–35.0) | -2 (-3 to 0) |  0.018* |
POD2 | 34.0 (32.0–37.0) | 38.0 (36.0–39.0) | -3 (-4 to -1) | 0.000* |
 |  |  |  | 0.789 0.018* 0.000* |